Dun & Bradstreet Holdings Inc
NYSE:DNB
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Dun & Bradstreet Holdings Inc
Cash Equivalents
Dun & Bradstreet Holdings Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dun & Bradstreet Holdings Inc
NYSE:DNB
|
Cash Equivalents
$188.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Booz Allen Hamilton Holding Corp
NYSE:BAH
|
Cash Equivalents
$554.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
Equifax Inc
NYSE:EFX
|
Cash Equivalents
$201m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
Leidos Holdings Inc
NYSE:LDOS
|
Cash Equivalents
$633m
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Verisk Analytics Inc
NASDAQ:VRSK
|
Cash Equivalents
$352.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-2%
|
|
CoStar Group Inc
NASDAQ:CSGP
|
Cash Equivalents
$5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
32%
|
CAGR 10-Years
164%
|
See Also
What is Dun & Bradstreet Holdings Inc's Cash Equivalents?
Cash Equivalents
188.1m
USD
Based on the financial report for Dec 31, 2023, Dun & Bradstreet Holdings Inc's Cash Equivalents amounts to 188.1m USD.
What is Dun & Bradstreet Holdings Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash Equivalents growth was -10%. The average annual Cash Equivalents growth rates for Dun & Bradstreet Holdings Inc have been -19% over the past three years , 16% over the past five years .